IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Diffuse Large B Cell Lymphoma
Related studies linked through entity extraction aliases.
Genotype-guided Treatment in DLBCL
- Status
- RECRUITING
- Phase
- PHASE3
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
ZR-CHOP in DLBCL With Specific Gene Abnormality
- Status
- RECRUITING
- Phase
- PHASE2
ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Safety, Efficacy and Pharmacokinetics of XKDCT023 in DLBCL
- Status
- UNKNOWN
- Phase
- NA
Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy
- Status
- RECRUITING
- Phase
- N/A
Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Phase II Study of Zanubrutinib, Lenalidomide Plus R-CHOP as the First-line Treatment for Diffused Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- N/A
The Use of Biomarkers to Predict CNS Involvement in Diffuse Large B-Cell Lymphoma: a Danish Nationwide Registry Study
- Status
- COMPLETED
- Phase
- N/A
Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL
- Status
- TERMINATED
- Phase
- PHASE1
CAR T Cell Therapy Related Cardiovascular Outcomes
- Status
- COMPLETED
- Phase
- N/A